02170.HK
Suzhou Basecare Medical Corporation Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 1.38
−2.82%Sep 16, 2026, 01:56 UTC
China's National Medical Products Administration included CSPC Pharmaceutical Group's SYS 6010 in the breakthrough therapy designation list for recurrent or metastatic driver-gene-negative non-squamous non-small cell lung cancer that failed prior immunotherapy and platinum-based chemotherapy.
Source:Sep 16, 2026, 01:53 UTC
Basecare Medical (02170.HK) announced that its Gems series vitrification freezing solution set and vitrification thawing solution set recently each obtained Class III medical device registration certificates issued by China's National Medical Products Administration.
Source:Aug 17, 2026, 01:32 UTC
Beike Medical issued a profit warning for the six months ended June 2026, expecting revenue of approximately RMB 126-131 million (up 24-29% year-on-year), net loss of RMB 69-73.5 million (narrowing 39.5-43.2%), and negative EBITDA of RMB 44.4-49 million (narrowing 46.9-51.9%).
Source: